Sale!

PRKAR1A Gene Carney Complex Type 1 NGS Genetic DNA Test

Original price was: $700.Current price is: $500.

-29%

The PRKAR1A Gene Carney Complex Type 1 NGS Genetic DNA Test is a comprehensive genetic analysis that detects mutations in the PRKAR1A gene associated with Carney complex, a rare inherited disorder that increases cancer risk. This advanced next-generation sequencing test provides crucial information for individuals with family history of Carney complex or related symptoms. The test helps identify genetic predisposition to various tumors including cardiac myxomas, skin pigmentation abnormalities, and endocrine disorders. With results available in 3-4 weeks, this $500 USD test offers valuable insights for early detection and proactive management strategies. Genetic counseling is recommended before testing to understand family inheritance patterns and potential implications.

Clinically Validated & Lab Certified

  • ISO-Accredited Laboratory, Ensuring Highest Standards
  • Trusted by Hospitals & Patients —Accredited Testing with Results
  • Direct Healthcare Provider Support + Comprehensive Reporting
Guaranteed Safe Checkout

PRKAR1A Gene Carney Complex Type 1 NGS Genetic DNA Test

Comprehensive Genetic Testing for Carney Complex Detection

The PRKAR1A Gene Carney Complex Type 1 NGS Genetic DNA Test represents a cutting-edge diagnostic approach for identifying genetic mutations associated with Carney complex, a rare inherited multiple neoplasia syndrome. This sophisticated genetic analysis utilizes next-generation sequencing technology to provide comprehensive insights into an individual’s genetic predisposition to this complex disorder.

What is Carney Complex?

Carney complex is an autosomal dominant condition characterized by the development of multiple tumors and pigmented lesions throughout the body. The condition primarily affects the PRKAR1A gene, which plays a crucial role in regulating cell growth and division. When mutations occur in this gene, it disrupts normal cellular processes, leading to uncontrolled growth and tumor formation.

What the Test Measures and Detects

This advanced genetic test specifically analyzes the PRKAR1A gene using next-generation sequencing technology to identify:

  • Point mutations in the PRKAR1A gene coding regions
  • Small insertions and deletions affecting gene function
  • Genetic variants associated with Carney complex type 1
  • Inheritance patterns of PRKAR1A mutations
  • Risk assessment for tumor development

The test provides comprehensive coverage of all exons and flanking intronic regions of the PRKAR1A gene, ensuring maximum detection sensitivity for clinically relevant variants.

Who Should Consider This Test

Clinical Indications and Symptoms

This genetic test is recommended for individuals experiencing or with family history of:

  • Cardiac myxomas: Benign tumors in the heart chambers
  • Skin pigmentation abnormalities: Spotty skin pigmentation, especially on lips and face
  • Endocrine tumors: Adrenal, pituitary, or thyroid gland abnormalities
  • Psammomatous melanotic schwannomas: Rare nerve sheath tumors
  • Family history: Known PRKAR1A mutations or Carney complex diagnosis in relatives
  • Unexplained endocrine overactivity: Cushing’s syndrome or acromegaly

High-Risk Populations

Individuals with the following characteristics should strongly consider testing:

  • First-degree relatives of Carney complex patients
  • Patients with multiple cardiac myxomas
  • Individuals with spotty skin pigmentation and endocrine abnormalities
  • Those with unexplained Cushing’s syndrome at young age
  • Patients with psammomatous melanotic schwannomas

Benefits of Taking the PRKAR1A Genetic Test

Early Detection and Prevention

Undergoing PRKAR1A genetic testing offers numerous advantages:

  • Early Risk Identification: Detect genetic predisposition before symptom onset
  • Personalized Surveillance: Implement targeted screening protocols
  • Family Planning Guidance: Make informed reproductive decisions
  • Proactive Management: Initiate preventive measures and early interventions
  • Reduced Anxiety: Clarify genetic status and associated risks
  • Comprehensive Care Planning: Coordinate multi-specialty medical care

Clinical Management Advantages

Positive test results enable healthcare providers to:

  • Establish regular cardiac monitoring for myxoma detection
  • Implement endocrine function surveillance protocols
  • Coordinate dermatological evaluations for skin manifestations
  • Develop personalized cancer screening schedules
  • Provide genetic counseling for at-risk family members

Understanding Your Test Results

Interpretation Guidelines

Your PRKAR1A genetic test results will fall into one of several categories:

  • Positive Result: A pathogenic mutation is identified, confirming Carney complex diagnosis and indicating increased tumor risk
  • Negative Result: No mutation detected, significantly reducing but not eliminating Carney complex risk
  • Variant of Uncertain Significance: Genetic change identified with unknown clinical implications requiring further evaluation
  • Benign Variant: Genetic change identified that does not increase disease risk

Next Steps After Testing

Based on your results, our genetic counselors will provide:

  • Comprehensive result interpretation and explanation
  • Personalized risk assessment and management recommendations
  • Family testing guidance and inheritance pattern education
  • Referrals to appropriate medical specialists
  • Long-term surveillance planning and follow-up care coordination

Test Information and Pricing

Test Parameter Details
Test Name PRKAR1A Gene Carney Complex Type 1 NGS Genetic DNA Test
Regular Price $700 USD
Discount Price $500 USD
Turnaround Time 3 to 4 Weeks
Sample Type Blood or Extracted DNA or One drop Blood on FTA Card
Testing Method Next-Generation Sequencing (NGS) Technology
Specialty Oncology Genetics

Pre-Test Requirements and Preparation

Essential Pre-Testing Steps

Before undergoing PRKAR1A genetic testing, patients must complete:

  • Comprehensive Clinical History: Detailed medical and family history documentation
  • Genetic Counseling Session: Professional counseling to understand test implications
  • Family Pedigree Chart: Creation of detailed family inheritance pattern diagram
  • Informed Consent: Understanding of potential outcomes and limitations
  • Insurance Verification: Confirmation of coverage and out-of-pocket costs

Nationwide Testing Availability

General Genetics Corporation provides comprehensive PRKAR1A genetic testing services across the United States. We have established testing facilities and collection centers in all major metropolitan areas including:

  • New York City and surrounding regions
  • Los Angeles and Southern California
  • Chicago and Midwest locations
  • Houston and Texas medical centers
  • Phoenix and Southwest facilities
  • Philadelphia and Northeast centers
  • All other major US cities and regions

Take Control of Your Genetic Health Today

Don’t wait to understand your genetic risk for Carney complex. Early detection through PRKAR1A genetic testing can significantly impact your long-term health outcomes and provide peace of mind for you and your family.

Call or WhatsApp us now at +1(267) 388-9828 to schedule your genetic counseling session and book your PRKAR1A Gene Carney Complex Type 1 NGS Genetic DNA Test.

Our dedicated genetic specialists are available to answer your questions, explain the testing process, and help you take the first step toward comprehensive genetic health assessment. With our discounted price of $500 USD and nationwide availability, there’s no better time to invest in your genetic future.